This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Dr. Dale Starkie, PhD
Director at DJS Antibodies
Speaker

Profile

Dale is a director of scientific research at DJS-AbbVie based in Oxford. His role is primarily to manage and guide antibody therapeutic programs from inception to the clinical proof of concept, as well as scientific operational oversite of the DJS-AbbVie site.

Over Dale’s career to date, he has worked on antibody and small molecule therapeutic programs across many areas including Immunology, oncology, neuroscience, fibrosis and viral disease. This work has led to Dale being involved in the delivery of many antibody candidates to clinical development and patients.

Agenda Sessions

  • Probing the Role of 4R-tau in 10+16 MAPT Mutant iPSC-derived Neurones via Isoform-specific Antibody-mediated Degradation

    15:05
  • Co-Chairs' Remarks

    08:15
  • Chairman's Remarks

    14:20